摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲氧基亚苯基肼 | 7466-54-8

中文名称
2-甲氧基亚苯基肼
中文别名
2-甲氧基苯甲酰肼;2-甲氧基苯酰肼
英文名称
2-methoxybenzoylhydrazine
英文别名
2-Methoxybenzhydrazide;2-methoxybenzohydrazide
2-甲氧基亚苯基肼化学式
CAS
7466-54-8
化学式
C8H10N2O2
mdl
MFCD00014755
分子量
166.18
InChiKey
QMGXWNSSMGAHCA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    78-80°C
  • 沸点:
    294.38°C (rough estimate)
  • 密度:
    1.2265 (rough estimate)
  • 稳定性/保质期:

    如果按照规格使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    64.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 危险类别码:
    R22,R36/37/38
  • WGK Germany:
    3
  • 安全说明:
    S26,S36
  • RTECS号:
    BZ4700000
  • 海关编码:
    2928000090
  • 危险性防范说明:
    P233,P260,P261,P264,P271,P280,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    密封在阴凉干燥的环境中。

SDS

SDS:66cabd2cdb3d022a840204e692bb014a
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Methoxybenzhydrazide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxybenzhydrazide
CAS number: 7466-54-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H10N2O2
Molecular weight: 166.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

类别:有毒物品

毒性分级:中毒

急性毒性:静脉-小鼠 LD50:178 毫克/公斤

可燃性危险特性:可燃;燃烧时产生有毒氮氧化物烟雾

储运特性:库房通风、低温干燥

灭火剂:干粉、泡沫、沙土、二氧化碳、雾状

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4
    • 5

反应信息

  • 作为反应物:
    描述:
    2-甲氧基亚苯基肼三溴化硼三乙胺三氯氧磷 作用下, 以 二氯甲烷氯仿 为溶剂, 反应 31.0h, 生成 2-(5-苯基-1,3,4-噁二唑-2-基)苯酚
    参考文献:
    名称:
    带有2-(5-苯基-1,3,4-恶二唑-2-基)-苯酚衍生物作为辅助配体的四种杂铱铱配合物的合成,光致发光和电致发光† ‡
    摘要:
    四个新的铱(III)环金属化配合物(Ir1-Ir4),以4-三氟甲基苯基吡啶为主要配体和2-(5-苯基-1,3,4-恶二唑-2-基)-苯酚及其氟/三氟甲基取代的衍生物已开发出辅助配体。所有配合物是绿色磷光体(λ最大= 519-537纳米)与CH的10-53%的光致发光量子效率的产率2氯2种溶液在室温下,分别。具有ITO / TAPC(1,1-双[4-(二-对甲苯基氨基)苯基]环己烷,60 nm)/ Ir配合物(8 wt%):SimCP2(bis [3,5-di(9 H-咔唑-9-基)苯基]二苯基硅烷,30 nm)/ TPBi(1,3,5-三(1-苯基-1 H-苯并[ d ]咪唑-2-基)苯基,90 nm)/ LiF( 1 nm)/ Al(100 nm)表现出良好的性能。特别地,设备G4基于复杂IR4(2-(5-五氟苯基-1,3,4-恶二唑-2-基) -苯酚作为辅助配体)显示出具有峰值电流效率优良性能(η
    DOI:
    10.1039/c3tc31915f
  • 作为产物:
    描述:
    邻甲氧基苯甲酸硫酸 作用下, 以 乙醇 为溶剂, 生成 2-甲氧基亚苯基肼
    参考文献:
    名称:
    合成与药理筛选:含 2-pipecoline 的 1,3,4-恶二唑核的磺胺衍生物
    摘要:
    亲电子试剂,1-(4-(溴甲基苯磺酰基)-2-甲基哌啶,由 2-甲基哌啶(2-哌啶)和 4-溴甲基苯磺酰氯在弱碱性介质中在 pH 控制下反应合成。一系列亲核试剂,5 -芳基/芳烷基-1,3,4-恶二唑-2-硫醇,由相应的羧酸分三步合成。标题分子是通过在非质子介质中使用LiH作为活化剂将亲电试剂与亲核试剂偶联来合成的。结构通过 IR、1H NMR 和 EI-MS 技术证实了所有合成的化合物。筛选了所有化合物的药理行为,特别是抗菌和酶抑制活性。对革兰氏阳性和革兰氏阴性都获得了显着的有效结果细菌菌株。关于酶抑制,化合物对乙酰胆碱酯酶和丁酰胆碱酯酶有效。
    DOI:
    10.1134/s1068162017030025
点击查看最新优质反应信息

文献信息

  • Synthesis and antiviral activity of novel thioether derivatives containing 1,3,4-oxadiazole/thiadiazole and emodin moieties
    作者:Liangrun Dong、Baojing Song、Jian Wu、Zengxue Wu、Yunying Zhu、Xuewen Chen、Deyu Hu
    DOI:10.1080/10426507.2015.1114944
    日期:2016.6.2
    ABSTRACT ABSTRACT A series of novel thioether derivatives containing 1,3,4-oxadiazole/thiadiazole and emodin moieties were designed and synthesized. The structures of the target compounds were confirmed by 1H NMR, 13C NMR, Infrared, and elemental analysis. The results of bioactivity analysis showed that most of the target compounds exhibited moderate to good antiviral activity against tobacco mosaic virus
    图形摘要 摘要 设计并合成了一系列含有 1,3,4-恶二唑/噻二唑大黄素部分的新型醚衍生物。目标化合物的结构经1H NMR、13C NMR、红外和元素分析确证。生物活性分析结果表明,大多数目标化合物在浓度为500 mg/L时对烟草花叶病毒表现出中等至良好的抗病毒活性。尤其是标题化合物中Y2、Y8和Y10在体内具有明显的治疗活性,抑制率分别为50.51、52.08和54.62%,与宁南霉素(53.40%)相似。
  • Discovery of Functionally Selective 7,8,9,10-Tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-<i>a</i>]phthalazines as GABA<sub>A</sub> Receptor Agonists at the α<sub>3</sub> Subunit
    作者:Michael G. N. Russell、Robert W. Carling、John R. Atack、Frances A. Bromidge、Susan M. Cook、Peter Hunt、Catherine Isted、Matt Lucas、Ruth M. McKernan、Andrew Mitchinson、Kevin W. Moore、Robert Narquizian、Alison J. Macaulay、David Thomas、Sally-Anne Thompson、Keith A. Wafford、José L. Castro
    DOI:10.1021/jm040883v
    日期:2005.3.1
    We have previously identified the 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazine (1) as a potent partial agonist for the alpha(3) receptor subtype with 5-fold selectivity in binding affinity over alpha(1). This paper describes a detailed investigation of the substituents on this core structure at both the 3- and 6-positions. Despite evaluating a wide range of groups, the maximum selectivity
    我们之前已经确定了7,8,9,10-四氢-7,10-乙醇-1,2,4-三唑并[3,4-a]酞嗪(1)是α(3)的有效部分激动剂。受体亚型,对α(1)的结合亲和力具有5倍的选择性。本文描述了在此核心结构的3位和6位上的取代基的详细研究。尽管评估了广泛的组,但相对于alpha(1)亚型,对alpha(3)亚型的亲和力可达到的最大选择性是12倍(对于57)。尽管大多数类似物在功效上均未显示选择性,但一些类似物确实在α(1)处表现出部分激动作用,而在α(3)处表现出拮抗作用(例如25和75)。但是,测试了两个类似物(93和96),它们都在6位上有三唑取代基,显示出对alpha(3)亚型的疗效明显高于alpha(1)亚型。这是该系列中可以在所需方向上实现选择性的第一个迹象。
  • Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors
    作者:Mehr-un Nisa、Munawar A. Munawar、Amber Iqbal、Asrar Ahmed、Muhammad Ashraf、Qurra-tul-Ann A. Gardener、Misbahul A. Khan
    DOI:10.1016/j.ejmech.2017.06.036
    日期:2017.9
    A novel series of 5-(aroylhydrazinocarbonyl)escitalopram (58–84) have been designed, synthesized and tested for their inhibitory potential against cholinesterases. 3-Chlorobenzoyl- (71) was found to be the most potent compound of this series having IC50 1.80 ± 0.11 μM for acetylcholinesterase (AChE) inhibition. For the butyrylcholinesterase (BChE) inhibition, 2-bromobenzoyl- (76) was the most active
    已经设计,合成和测试了一系列新型的5-(芳酰基基羰基)依他普仑(58-84)对胆碱酯酶的抑制潜力。发现3-氯苯甲酰基- (71)是该系列中最有效的化合物,对乙酰胆碱酯酶(AChE)的抑制作用的IC 50为1.80±0.11μM。对于丁酰胆碱酯酶(BChE)抑制,2-溴苯甲酰基-(76)是该系列中活性最高的化合物,IC 50为2.11±0.31μM。构效关系说明温和的给电子基团增强了酶的抑制作用,而吸电子基团降低了除o -NO 2以外的抑制。然而,取代基的大小和位置影响酶抑制。。在AChE的对接研究中,配体71、72和76分别显示5874、5756和5666以及ACE的得分分别为-64.92,-203.25和-140.29 kcal / mol。在BChE的情况下,配体71、76和81分别显示出ACE值为-170.91,-256.84和-235.97 kcal / mol的高分6016、6150和5994。
  • Ultrasound-assisted, one-pot, three-component synthesis and antibacterial activities of novel indole derivatives containing 1,3,4-oxadiazole and 1,2,4-triazole moieties
    作者:Zhichuan Shi、Zhigang Zhao、Meiwei Huang、Xiaolin Fu
    DOI:10.1016/j.crci.2015.09.005
    日期:2015.12
    Résumé Thirteen novel indole derivatives were efficiently synthesized through ultrasound irradiation by using 4-amino-5-(1H-indol-3-yl)-4H-[1,2,4]triazole-3-thiol (8) and 2-mercapto-5-substituted-1,3,4-oxadiazoles (5a–m). Compared with conventional and microwave methods, yields increased to 82–93%, and reaction times decreased to 15–35 min. The structures of these novel compounds were characterized by spectral data and elemental analysis. Two out of the synthesized compounds (10f and 10l) exhibited excellent activity against Staphylococcus aureus and Escherichia coli, and thus warrant further research. Supplementary Materials: Supplementary material for this article is supplied as a separate file: mmc1.pdf
    摘要 通过超声辐照,以4-基-5-(1H-吲哚-3-基)-4H-[1,2,4]三唑-3-醇(8)和2-巯基-5-取代的-1,3,4-噁二唑(5a–m)为原料,高效合成了十三种新型吲哚生物。与传统方法和微波方法相比,产率提高到82–93%,反应时间缩短到15–35分钟。这些新化合物的结构通过光谱数据和元素分析得到表征。合成的化合物中有两种(10f和10l)对黄色葡萄球菌和大肠杆菌显示出优异的活性,因此值得进一步研究。 补充材料: 本文的补充材料以单独文件形式提供:mmc1.pdf
  • Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues
    作者:Khalid Mohammad Khan、Maimona Rasheed、Zia Ullah、Safdar Hayat、Farhana Kaukab、M.Iqbal Choudhary、Atta ur-Rahman、Shahnaz Perveen
    DOI:10.1016/s0968-0896(02)00611-9
    日期:2003.4
    Twenty-one hydrazides were synthesized by treating different esters with hydrazine hydrate. Substituted hydrazides were obtained by treating hydrazides with alkyl/aryl/acyl halides. Some of these compounds exhibit potential in vitro leishmanicidal activity. The structures of all the synthesized compounds were confirmed by spectroscopic analysis.
    通过用处理不同的酯来合成二十一个酰。通过用烷基/芳基/酰基卤化物处理酰得到取代的酰。这些化合物中的某些表现出潜在的体外杀菌作用。所有合成化合物的结构通过光谱分析确认。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫